Strategic Financial Services’s NovoCure NVCR Stock Holding History

Strategic Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,090	Closed	-$242K	–	139
2021 Q2	$242K	Sell	1,090 -2,700	-71%	-$525K	0.02%	130
2021 Q1	$501K	Hold	3,790	–	–	0.04%	92
2020 Q4	$656K	Hold	3,790	–	–	0.06%	86
2020 Q3	$422K	Hold	3,790	–	–	0.04%	93
2020 Q2	$225K	Sell	3,790 -1,250	-25%	-$82.2K	0.03%	120
2020 Q1	$339K	Buy	5,040 +1,290	+34%	+$102K	0.05%	100
2019 Q4	$316K	Hold	3,750	–	–	0.04%	121
2019 Q3	$280K	Sell	3,750 -550	-13%	-$44K	0.04%	123
2019 Q2	$272K	Hold	4,300	–	–	0.04%	122
2019 Q1	$207K	Buy	+4,300	New	+$207K	0.03%	127
2018 Q4	–	Sell	-5,000	Closed	-$262K	–	140
2018 Q3	$262K	Buy	+5,000	New	+$199K	0.04%	111

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strategic Financial Services's NVCR Position: Q3 2021 in Review

Strategic Financial Services sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,090 shares — an estimated $242K sold.

Strategic Financial Services first reported a position in NVCR in Q3 2018 and held it in 11 quarters. The position peaked at $656K in Q4 2020. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

Strategic Financial Services reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
Strategic Financial Services sold 1,090 NovoCure shares in Q3 2021, an estimated $242K.
Strategic Financial Services first reported a position in NovoCure in Q3 2018 and held it in 11 quarters.
Strategic Financial Services's NovoCure position peaked at $656K in Q4 2020.
317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Strategic Financial Services's 13F filing for Q3 2021, filed 15 Nov 2021.